Successfully Fast-Track Your LNPs from Concept to Market at the Largest Meeting Dedicated Purely to LNPs Worldwide
With Arbor Biotechnologies on-track for year-end IND/CTA filing of their LNP-mediated gene editing therapy and LNPs continuing to be the hottest delivery vehicle across all payload types, completely dominating the non-viral delivery field, the promise of this delivery vehicle is truly exciting!
The 4th LNP Formulation & Process Development Summit returns to Boston, as the only industry summit dedicated to showcasing the hottest pre-clinical and clinical data, overcoming the greatest challenges within the LNP IP space and uncovering the most innovative LNP formulations for cell-specific delivery outside the liver.
With a revamped track design, the 2025 meeting has 3 dedicated streams, Analytical Development & Characterization, Formulation & Delivery and Process Development & Manufacturing to deep dive into an end-to-end strategy for revolutionizing the development of potent, safe and stable LNPs for a variety of payloads.
Uniting 300+ LNP trailblazers from across the globe, this is your one-stop-shop for LNP specific networking, partnership opportunities and collaborative discussions to further fuel advancement of LNPs towards clinical development and beyond.
2025 Expert Speakers Include:
Muthiah (Mano) Manoharan
Senior Vice President, Innovation Chemistry & Alnylam Distinguished Scientist
Alnylam Pharmaceuticals
Brand New Presenting Companies:
What’s New in 2025?
In addition to the unrivalled scientific content in the form of presentations, roundtable discussion, panels and workshops, there will be a variety of extra experiences allowing for maximum ROI out of your time at the conference.
Refreshed Conference Streams
We’ve strengthened this year’s conference with industry experts to ensure it remains comprehensive and highlights the industry’s most relevant areas of interest. This year offers three parallel tracks – Analytical Development & Characterization, Formulation & Delivery and Process Development & Manufacturing - designed to optimize your LNP development
LNP 101 Day
Join the 101 Day to equip you and your team with the essential tools and fundamental principles for successful LNP development, showcasing the full potential of LNPs across various payloads and disease areas led by the likes of AstraZeneca, Takeda, Regeneron & more.
2-Track Workshop Day
The Pre-Conference Workshop Day will deep dive into key challenges, including lipid library development, extrahepatic delivery, optimizing CMC of LNPs and overcoming IP bottlenecks, to accelerate novel and innovative LNPs towards the market.
Poster Session
Interested in hearing what your peers are up to, or even sharing research of your own? The poster session will unleash the latest innovations as part of the main conference program for no extra charge.
Networking Opportunities
Nothing embodies the LNP Formulation & Process Development Summit like our dedicated networking opportunities! The 2025 event will feature a drinks reception, speed networking sessions, lunch briefings, and more, bringing together over 300 biopharma experts committed to advancing LNPs.
New! Awards Evening & Drinks Reception
The inaugural LNP Awards will take place at the 2025 summit, honoring success, progress, and achievements within the LNP community. Join us as you and fellow industry members recognize and celebrate the best that the LNP sector has to offer.
What Previous Attendees of the LNP Series Had To Say:
This meeting is an excellent opportunity to connect with my counterparts in the biotech community and learn about the latest progress and challenges in advancing LNPs towards new medicinal products
Vice President, Head of Process Development, Sail Biomedicines
For professionals interested in deepening their understanding of Lipid Nanoparticles (LNPs) or seeking a comprehensive update in this field, I highly recommend attending this conference. This event will provide an invaluable overview of the current industry landscape and emerging trends in LNP technology
Scientist, Takeda Pharmaceuticals
Attending the 4th LNP Formulation & Process Development Summit provides significant value. It offers an excellent platform for engaging with experts and discussing the latest advancements in LNP technology.
Director, Non-Viral Delivery, Mammoth Biosciences